New Marchand Institute Study Shows effect of a 20% intravenous fat emulsion therapy on IVF and ICSI

Just published in the Journal of Clinical and Translational Research, The Marchand Institute’s new study on 20% intravenous fat emulsion therapy (also known as Intralipid^TM), shows the effect of this medication on patients who suffer from recurrent pregnancy loss (RPL) and recurrent implantation failure (RIF) who are seeking to conceive via invitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). The article is available online complete free at the US Government’s Pubmed website as well as Semantic Scholar^TM.

Robotic vs. Non-Robotic Single-Site Hysterectomy: Marchand Institute’s New Meta-Analysis Provides Clarity on Surgical Outcomes
February 20, 2026

Exciting News: Marchand Institute’s Latest Meta-Analysis on Opportunistic Salpingectomy for Epithelial Ovarian Cancer Prevention is Published and Open Access!
February 5, 2026

New Systematic Review and Meta-Analysis: Comparative Risk of Neonatal Ischemic Encephalopathy in Operative Vaginal Delivery vs. Cesarean at Complete Dilation – Now Online in AJP!
January 29, 2026

Newest Paper on Laparoscopic Single Site Ovarian Cystectomy Online Now!
January 1, 2026

New Systematic Review Reveals Gynecologic Surgeons Achieve Superior Outcomes in Pediatric Adnexal Mass Surgery – Now Freely Available Online!
December 18, 2025

The Marchand Institute’s Analysis of Self Collected Pap Smears online today in AJOG!
November 18, 2025